|
|  |  | | News |  |  | Nature Biotechnology 23, 1323 - 1324 (2005)
Published online: 1 November 2005; | doi:10.1038/nbt1105-1323
First-in-class biologic to enter rheumatoid arthritis frayKen Garber
Ann Arbor, Michigan
A completely novel biologic for the treatment of rheumatoid arthritis is poised to enter the US market.
|
|  | |